29 August 2023
Approximately 15% of patients show no response to neoadjuvant chemoradiotherapy for the treatment of locally advanced rectal cancer before surgery. August’s Paper of the Month looks at a systematic review aiming to identify biomarkers of innate radioresistant rectal cancer.